Cabaletta Bio, Inc. Profile Avatar - Palmy Investing

Cabaletta Bio, Inc.

Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor…

Biotechnology
US, Philadelphia [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

Cabaletta Bio, Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

Cabaletta Bio, Inc. can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of Cabaletta Bio, Inc..

End of CABA's Analysis
CIK: 1759138 CUSIP: 12674W109 ISIN: US12674W1099 LEI: - UEI: -
Secondary Listings
CABA has no secondary listings inside our databases.